SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Bio-Tech (India) Ltd (539470)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 539470 NSE: Agriculture | Small Cap | Shree Ganesh BioTech Share Price

₹0.61 0.02 (3.39%)

As on 05-Jun'26 16:59

Shree Ganesh Bio-Tech (India) Ltd (539470)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 539470 NSE: Agriculture | Small Cap | Shree Ganesh BioTech Share Price

₹0.61 0.02 (3.39%)

As on 05-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹24 Cr.
Current Price
₹0.6
52-Week Low / High
₹1 / 1
TTM EPS
₹0
TTM Sales
₹5 Cr.
Book Value per Share
₹1.6
P/E Ratio
62.55
Higher than its 5-year historical median
Industry PE
15.5
Price to Book (P/B)
0.37
Lower than its 5-year historical median
Price to Sales (P/S)
4.73
Higher than its 5-year historical median
EV/EBITDA
45.74
In line with its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
0.44%
Underperforms industry median
Return on Capital Employed (ROCE)
0.61%
Underperforms industry median
Return on Assets (ROA)
0.41%
Operating Profit Margin
-4.2%
Net Profit Margin
1.21%
Gross Profit Margin
1.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
13.21%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-54.84%
Asset Quality
Promoter Holding
0.00%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹24 Cr.
Equity
₹39.9 Cr.
Face Value
₹1
All Time Low / High
₹0.54 / 24.70

Shree Ganesh Bio-Tech (India) stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Shree Ganesh Bio-Tech (India) Ltd a good quality company?
Shree Ganesh Bio-Tech (India) Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Shree Ganesh Bio-Tech (India) Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Shree Ganesh Bio-Tech (India) Ltd vs industry peers?
Shree Ganesh Bio-Tech (India) Ltd revenue CAGR is 56.19%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Shree Ganesh Bio-Tech (India) Ltd?
Promoters hold 0.00% of the Shree Ganesh Bio-Tech (India) Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Shree Ganesh Bio-Tech (India) Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -36.86% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Shree Ganesh Bio-Tech (India) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 12.3%30.4%16.5%4.5%0.4%0.7%5.9%4.4%1.4%0.6%-
Value Creation
Index
-0.11.20.2-0.7-1.0-1.0-0.6-0.7-0.9-1.0-

Growth Parameters

Sales 2.18.57.95.92.517.272.662.520.3235
Sales YoY Gr.-302.8%-8%-25.3%-57.9%596.8%322.1%-14%-67.5%13.2%-
Adj EPS 0.3110000.10.1000
YoY Gr.-251.7%-5.9%-95.8%-75%0%500%-16.7%-60%-50%-
BVPS (₹) 2.62.33.31.41.41.51.51.61.61.61.6
Adj Net
Profit
0.53.73.51.80.20.52.51.90.60.30
Cash Flow from Ops. -0-12.92.2-0.5-12.43.610.510.2-10.2-
Debt/CF from Ops. -11.8-00.1-0.4-0.20.10000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 30.3%56.2%-31.9%13.2%
Adj EPS -31.2%0%-45%-50%
BVPS-5.4%2%1.7%0.6%
Share Price - -36.8% -15.8% -31.5%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
1230.916.64.50.40.94.23.110.50.6
Op. Profit
Mgn %
31.144.144.630.59.64.14.83.4-1-4.2-19.3
Net Profit
Mgn %
25.443.744.630.59.533.433.11.58
Debt to
Equity
0.10000000000
Working Cap
Days
4274741,0632,8109,5001,4444074951,3701,014522
Cash Conv.
Cycle
3732483745381,6582595236-39-25475

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales2.128.547.865.872.4717.2172.6462.4520.2822.96
Operating Expenses + 1.464.784.364.082.2416.5169.1960.3020.4824.01
Manufacturing Costs0.040.0200000000
Material Costs14.023.373.361.5816.3368.8459.6320.0322.64
Employee Cost 0.170.100.100.090.060.080.250.220.180.10
Other Costs 0.250.640.890.630.590.100.110.460.261.27
Operating Profit 0.663.763.501.790.240.713.452.15-0.20-1.05
Operating Profit Margin (%) 31.1%44.1%44.6%30.5%9.6%4.1%4.7%3.4%-1.0%-4.6%
Other Income + 0.04000000.050.561.061.44
Exceptional Items 00000-0.280000
Interest 0.070.0300000000
Depreciation 0.07000000000
Profit Before Tax 0.553.733.501.790.240.433.502.710.850.39
Tax 0.0100000.110.970.680.230.11
Profit After Tax 0.543.733.501.790.240.322.532.040.620.28
PAT Margin (%) 25.4%43.7%44.6%30.5%9.5%1.8%3.5%3.3%3.1%1.2%
Adjusted EPS (₹)0.21.01.00.00.00.00.10.10.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Shree Ganesh BioTech - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 4.788.5112.0157.2457.4857.7960.3262.3662.9863.26
Share Capital 1.831.831.8319.9319.9319.9319.9339.8639.8639.86
Reserves 2.946.6810.1837.3137.5437.8640.3922.4923.1223.39
Debt +0.500.060.190.190.190.190000
Long Term Debt00.060.190.190.190.190000
Short Term Debt0.50000000000
Minority Interest0000000000
Trade Payables00.013.306.667.0516.5332.3116.4910.360
Others Liabilities 0.0310.8610.86-0-00.120.930.680.280.23
Total Liabilities 5.3019.4526.3664.0964.7274.6393.5579.5273.6263.49

Fixed Assets

Net Fixed Assets +2.32000.01000000
Gross Block2.92000.010.010.010.010.010.010.01
Accumulated Depreciation0.60000000000.01
CWIP 0000000000
Investments 0.2100003.063.22009.15
Inventories0000000002.89
Trade Receivables2.658.9913.5219.1620.7928.3443.8919.333.300
Cash Equivalents 0.010.030.030.040.020.020.040.480.430.01
Others Assets 0.1110.4312.8244.8843.9043.2046.4159.7169.8951.43
Total Assets 5.3019.4526.3664.0964.7274.6393.5579.5273.6263.49

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -0.04-12.942.23-0.50-1.012.363.5710.5410.16-10.21
PBT 0.553.733.501.790.240.433.502.710.850.39
Adjustment 0.07000000000
Changes in Working Capital -0.67-16.67-1.27-2.29-1.252.051.048.59.54-10.49
Tax Paid 00000-0.11-0.97-0.68-0.23-0.11
Cash Flow From Investing Activity + 02.53-2.36-32.070.99-2.36-3.37-10.09-10.219.80
Capex 02.32-0-0.01000000
Net Investments 00.21000-3.06-0.163.220-9.15
Others 00-2.36-32.060.990.70-3.21-13.31-10.2118.95
Cash Flow From Financing Activity + -0.1110.420.1332.5800-0.19000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others -0.1110.420.1332.5800-0.19000
Net Cash Flow -0.160.0200.01-0.020.010.010.44-0.05-0.41

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)11.9756.234.125.170.410.554.283.320.990.44
ROCE (%)12.330.4416.484.450.410.745.924.431.360.61
Asset Turnover Ratio0.410.690.340.130.040.250.860.720.260.33
PAT to CFO Conversion(x)-0.07-3.470.64-0.28-4.217.381.415.1716.39-36.46
Working Capital Days
Receivable Days331.60248.80522.801,016.302,948.40520.90181.50184.70203.700
Inventory Days00000000046
Payable Days01179.70541.301,588.50263.50129.50149.40244.600

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Shree Ganesh Bio-Tech (India) Ltd FAQs

The current trading price of Shree Ganesh BioTech on 05-Jun-2026 16:59 is ₹0.61.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Shree Ganesh BioTech stood at ₹23.52 Cr

The latest P/E ratio of Shree Ganesh BioTech as of 04-Jun-2026 is 62.55.

The latest P/B ratio of Shree Ganesh BioTech as of 04-Jun-2026 is 0.37.

The 52-week high of Shree Ganesh BioTech is ₹0.89 and the 52-week low is ₹0.54.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shree Ganesh BioTech is ₹4.97 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Shree Ganesh Bio-Tech (India) Ltd is a below average quality company.

The key valuation ratios of Shree Ganesh Bio-Tech (India) Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shree Ganesh Bio-Tech (India) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Shree Ganesh Bio-Tech (India) Ltd

Shree Ganesh Bio-Tech (India) Limited was incorporated under the Companies Act, 1956 on September 2, 1982, as S.P. Commercial Co. Limited under the Registrar of Companies, West Bengal. The Company got the Certificate of Commencement of Business on September 14, 1982 from the Registrar of Companies, West Bengal. The Company was incorporated with an object to carry on the business of builders, Contractors and to deal in property and also to do investment and finance business.

In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the High Court at Calcutta dated February 15, 2010. The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.P. Commercial Co. Limited. Subsequently, Shree Ganesh Bio-Tech (India) Private Limited was dissolved pursuant to the said Scheme of Amalgamation and the name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited. The name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited and a fresh certificate of incorporation consequent up on the change of name dated March 7, 2011 was issued by the Registrar of Companies, West Bengal.

Business area of the company

The company is engaged in the business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×